Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

Opinion & Analysis (TSX:VRX)

    What Andy Grove and Michael Milken have taught us about prostate cancer

    The Life Sciences Report April 20, 2016

    Drug pricing, presidential politics, and three biotechs with promise

    The Life Sciences Report April 13, 2016

    This ETF Has A Valeant Problem

    Benzinga.com  September 30, 2015

    Using ETFs To Run Your Own Hedge Fund

    Benzinga.com  August 20, 2015

    Lone Pine Capital Shuffles Its Top 5 Positions

    Benzinga.com  May 18, 2015

    Magna International (T.MG) shareholders bask in glow of rising share price

    Stockhouse Editorial April 22, 2014

    Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga.com  April 22, 2014

    ETF Outlook For Tuesday, April 22, 2014 (PBS, IHE, IYT, EIRL, VRX, AGN, NFLX)

    Benzinga.com  April 22, 2014

    Canadian Biotech comes back to life: A buyer's guide

    Tony Pullen January 21, 2014

    Bioniche digs in for fight with dissidents

    Peter Kennedy May 31, 2013